These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8967670)

  • 1. Pulmonary hypertension developing after alglucerase therapy in two patients with type 1 Gaucher disease complicated by the hepatopulmonary syndrome.
    Dawson A; Elias DJ; Rubenson D; Bartz SH; Garver PR; Kay AC; Bloor CM; Beutler E
    Ann Intern Med; 1996 Dec; 125(11):901-4. PubMed ID: 8967670
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulmonary hypertension in two patients with type I Gaucher disease while on alglucerase therapy.
    Harats D; Pauzner R; Elstein D; Many A; Klutstein MW; Kramer MR; Farfel Z; Zimran A
    Acta Haematol; 1997; 98(1):47-50. PubMed ID: 9210915
    [No Abstract]   [Full Text] [Related]  

  • 3. Alglucerase treatment of type 1 Gaucher disease with pulmonary involvement.
    Martinez Odrizola P; Ferrero O; Jauregui I; Miguel F
    Respir Med; 1998 Dec; 92(12):1370-2. PubMed ID: 10197233
    [No Abstract]   [Full Text] [Related]  

  • 4. Pulmonary arterial hypertension with plexogenic arteriopathy in enzyme-substituted Gaucher disease.
    den Bakker MA; Grünberg K; Boonstra A; van Hal PT; Hollak CE
    Histopathology; 2012 Aug; 61(2):324-6. PubMed ID: 22690977
    [No Abstract]   [Full Text] [Related]  

  • 5. Pulmonary hypertension in type 1 Gaucher's disease. Comité d'Evaluation du Traitement de la Maladie de Gaucher.
    Belmatoug N; Launay O; Carbon C
    Lancet; 1998 Jul; 352(9123):240. PubMed ID: 9683246
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe pulmonary hypertension and amelioration of hepatopulmonary syndrome after liver transplantation.
    Kaspar MD; Ramsay MA; Shuey CB; Levy MF; Klintmalm GG
    Liver Transpl Surg; 1998 Mar; 4(2):177-9. PubMed ID: 9516572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gaucher disease: resetting the clinical and scientific agenda.
    Mistry PK; Weinreb NJ; Brady RO; Grabowski GA
    Am J Hematol; 2009 Apr; 84(4):205-7. PubMed ID: 19296473
    [No Abstract]   [Full Text] [Related]  

  • 8. Rebound hepatosplenomegaly in type 1 Gaucher disease.
    Tóth J; Erdos M; Maródi L
    Eur J Haematol; 2003 Feb; 70(2):125-8. PubMed ID: 12581195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IV epoprostenol in Gaucher's disease.
    Elstein D; Zimran A
    Chest; 2000 Jun; 117(6):1821. PubMed ID: 10858430
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathologic fractures may develop in Gaucher patients receiving enzyme replacement therapy.
    Sidransky E; Ginns EI; Westman JA; Ehmann WC
    Am J Hematol; 1994 Nov; 47(3):247-9. PubMed ID: 7942798
    [No Abstract]   [Full Text] [Related]  

  • 11. Anaphylactoid reaction to imiglucerase, but not to alglucerase, in a type I Gaucher patient.
    Aviner S; Levy Y; Yaniv I; Cohen IJ
    Blood Cells Mol Dis; 1999 Apr; 25(2):92-4. PubMed ID: 10389590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary hypertension in Gaucher's disease.
    Pastores GM; Miller A
    Lancet; 1998 Aug; 352(9127):580. PubMed ID: 9716094
    [No Abstract]   [Full Text] [Related]  

  • 13. Alglucerase for Gaucher's disease.
    Med Lett Drugs Ther; 1991 Aug; 33(851):82. PubMed ID: 1865852
    [No Abstract]   [Full Text] [Related]  

  • 14. [An autopsied case of primary pulmonary hypertension complicated by hepatopulmonary syndrome].
    Tasaka S; Kanazawa M; Nakamura H; Matsumoto M; Mori M; Yamaguchi K; Handa S; Kuramochi S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Jan; 33(1):90-4. PubMed ID: 7699975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone crises in Gaucher disease.
    Cohen IJ
    Isr Med Assoc J; 2003 Nov; 5(11):838-9. PubMed ID: 14650121
    [No Abstract]   [Full Text] [Related]  

  • 16. [Alglucerase treatment of type I Gaucher's disease. Preliminary results in Spain. Spanish Group on Gaucher's Disease].
    Pérez-Calvo JI; Giraldo P; Giralt M
    Sangre (Barc); 1997 Jun; 42(3):189-94. PubMed ID: 9381260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholangiocarcinoma occurring in a patient with type 1 Gaucher disease treated with velaglucerase alfa enzyme replacement therapy: First case report.
    Holubar J; Bres V; Costes-Martineau V; Pers YM
    Blood Cells Mol Dis; 2018 Feb; 68():112-114. PubMed ID: 28559130
    [No Abstract]   [Full Text] [Related]  

  • 18. The female Gaucher patient: the impact of enzyme replacement therapy around key reproductive events (menstruation, pregnancy and menopause).
    Zimran A; Morris E; Mengel E; Kaplan P; Belmatoug N; Hughes DA; Malinova V; Heitner R; Sobreira E; Mrsić M; Granovsky-Grisaru S; Amato D; vom Dahl S
    Blood Cells Mol Dis; 2009; 43(3):264-88. PubMed ID: 19502088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alglucerase (Ceredase).
    Wiltink EH; Hollak CE
    Pharm World Sci; 1996 Jan; 18(1):16-9. PubMed ID: 8861826
    [No Abstract]   [Full Text] [Related]  

  • 20. Pregnancy after avascular necrosis of the femur complicating Gaucher's disease.
    Cleary JE; Burke WM; Baxi LV
    Am J Obstet Gynecol; 2001 Jan; 184(2):233-4. PubMed ID: 11174510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.